000 01437 a2200397 4500
005 20250515132914.0
264 0 _c20090126
008 200901s 0 0 eng d
022 _a1175-0561
024 7 _a10.2165/00128071-200809050-00007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMignogna, Michele Davide
245 0 0 _aAdjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study.
_h[electronic resource]
260 _bAmerican journal of clinical dermatology
_c2008
300 _a323-31 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPemphigus
_xdrug therapy
650 0 4 _aRetrospective Studies
650 0 4 _aStatistics, Nonparametric
650 0 4 _aTreatment Outcome
700 1 _aLeuci, Stefania
700 1 _aFedele, Stefano
700 1 _aRuoppo, Elvira
700 1 _aAdamo, Daniela
700 1 _aRusso, Giuseppina
700 1 _aPagliuca, Raffaella
773 0 _tAmerican journal of clinical dermatology
_gvol. 9
_gno. 5
_gp. 323-31
856 4 0 _uhttps://doi.org/10.2165/00128071-200809050-00007
_zAvailable from publisher's website
999 _c18189703
_d18189703